World's first AI-designed vaccine developed by UK scientists enters human trials

A groundbreaking AI-designed vaccine for Crimean-Congo haemorrhagic fever has entered human trials, marking a world-first for medical research. Developed by Oxford University and Basecamp Research, this initiative showcases AI's potential to drastically accelerate vaccine development for emerging infectious diseases. The trial aims to assess safety and immune response, potentially ushering in a new era of AI-assisted medicine.

By TOI World Desk